Welcome! You are visiting the MyeloRx web site.

Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
Lead Compounds
 
Isolated from plants
 
Semi-synthetic derivatives
 
Broad anti-tumor activity vs both solid tumors and leukemias in preclinical models
 
Especially active vs leukemia cell lines and primary acute myeoid blasts
 
Clinicall effective in leukemia and rheumatoid arthritis